Research article
220 views
Pharmacological mechanisms contributing to the clinical efficacy of levosimendan
Cardiovascular drug reviews, vol. 23, no. 1, pp. –, 1970
Abstract
Acute decompensation of chronic heart failure is a direct life-threatening situation with short-term mortality approaching 30%. A number of maladaptive changes are amplified within the cardiovascular system during the progression of chronic heart failure that makes the decompensation phase difficult …
Keywords
- National Center for Biotechnology Information
- NCBI
- NLM
- MEDLINE
- review
- animals
- humans
- pubmed abstract
- nih
- national institutes of health
- national library of medicine
- research support
- non-u.s. gov't
- chronic disease
- pyridazines / metabolism
- simendan
- pmid:15867949
- doi:10.1111/j.1527-3466.2005.tb00158.x
- zoltán papp
- kálmán csapó
- istván edes
- heart failure / drug therapy
- hydrazones / metabolism
- hydrazones / pharmacology*
- hydrazones / therapeutic use*
- pyridazines / pharmacology*
- pyridazines / therapeutic use*
- treatment outcome*
How to cite
Papp Z; Csapó K; Pollesello P; Haikala H; Edes I. (1970). Pharmacological mechanisms contributing to the clinical efficacy of levosimendan. Cardiovascular drug reviews, 23(1), –. https://www.ncbi.nlm.nih.gov/pubmed/15867949
Ref key
z1970cardiovascularpharmacological
Type this key in a SciMatic manuscript or in Thesis Manager to cite this paper automatically.
References
No references are recorded for this paper yet.
